Trexquant Investment’s Thermo Fisher Scientific TMO Stock Holding History

Trexquant Investment’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.71M	Buy	+9,400	New	+$4.51M	0.03%	778

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Trexquant Investment's TMO Position: Q3 2025 in Review

Trexquant Investment sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 9,930 shares — an estimated $4.03M sold.

Trexquant Investment first reported a position in TMO in Q4 2014 and held it in 20 quarters. The position peaked at $54M in Q2 2024. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Trexquant Investment reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Trexquant Investment sold 9,930 Thermo Fisher Scientific shares in Q3 2025, an estimated $4.03M.
Trexquant Investment first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 20 quarters.
Trexquant Investment's Thermo Fisher Scientific position peaked at $54M in Q2 2024.
2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.